Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness.
Process control, quality management and training operators are areas where biomanufacturers can learn from small molecule makers, according to preliminary results from a BioPlan Associates survey.
NIBRT is embracing continuous bioprocessing says training director John Milne, who told us the method helps improve plant flexibility and could reduce manufacturing costs.
The bio supply chain could learn some lessons from the small molecules sector. Even though a continuous expansion of rates above the traditional NCE sector, the supply chain can accelerate...
As Europe's growing biomanufacturing and bioprocessing industries develop, now a crucial time for the small-molecule and biopharma industries to integrate in order to facilitate growth.
When it comes to outsourcing process validation of biologics, Abel Hastings, director of process sciences at FUJIFILM Diosynth Biotechnologies, says that the relationship between a contract...
A biopharmaceutical revolution is sweeping pharmaceutical R&D laboratories and its echoes are driving innovation across the industry, including in the development of primary packaging and...
Samsung Biologics corners CMO market for bio. CEO Dr. Kim's keynote speech at the CPhI Worldwide Pre-connect Congress 2017.
As the industry globalises, the integration of the supply chain is forming a critical issues, markets now forecast a revival in European manufacturing and biotech.
UBM’s pharma portfolio announces the launch of a new bespoke and independently branded biopharma event, BioLIVE, specifically for bioprocessing and manufacturing.